Acquisition of Pfizer Assets by Lilly Cleared
25 May 2010EU - The European Commission has cleared the acquisition of animal health assets of Pfizer by Eli Lilly & Co.
The European Commission has granted clearance under the EU Merger Regulation to the acquisition of animal health assets of Pfizer by Eli Lilly & Co, both of the US.
Eli Lilly is a research-based, global pharmaceutical company engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products for humans and animals. Pfizer is active in the production of vaccines for animals.
The operation was examined under the simplified merger review procedure.
Further Reading
| - | Go to our previous news item on this story by clicking here. |
| ThePigSite News Desk | Read more Pfizer Animal Health News here |





















© 2000 - 2012. 5m Publishing, Benchmark House, 8 Smithy Wood Drive, Sheffield, S35 1QN, England.